Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/91lUVskQpT New @CochraneBCancer systematic review included 15 studies involving 11,538 women; these studies were conducted from 19
RT @WileyOnc_Hem: Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer. New @Co…
Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer. New @CochraneBCancer systematic review included 15 studies involving 11,538 women #breastcancer @CochraneLibrary https://t.co/jTvxS2wMUU http
RT @CochraneBCancer: New systematic review - ovarian function suppression for treating premenopausal women with hormone receptor‐positive e…
RT @CochraneBCancer: New systematic review - ovarian function suppression for treating premenopausal women with hormone receptor‐positive e…
New systematic review - ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/Uqi0mCmtJI
RT @Cochrane_US: Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t…
Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/3nDPfpgi23 New @CochraneBCancer systematic review included 15 studies involving 11,538 women; the studies were conducted from 1978
RT @VCCLibrary: Updated Cochrane Review: Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer https:…
Updated Cochrane Review: Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer https://t.co/8NdExRqh4F #breastcancer
RT @CochraneLibrary: Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https…
RT @CochraneLibrary: Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https…
Ovarian function suppression for treating premenopausal women with hormone receptor‐positive early breast cancer https://t.co/UL77wCFnCi New @CochraneBCancer systematic review included 15 studies involving 11,538 women; these studies were conducted from 19
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer. https://t.co/AQnWvKHi5v